Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab

• Autors principals: Hock Gin Teo (Autor), Tzyy Huei Lim (Autor), Kin Fon Leong (Autor), Pubalan Muniandy (Autor)
• Format: Llibre
• Publicat: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Pemphigus foliaceus (PF) is uncommon among children. The usage of rituximab in childhood PF is even less documented. We reported a case of a 16-year-old boy with juvenile PF who failed conventional treatments and was started on combination therapy of intravenous immunoglobulin (IVIG) and rituximab f...